As an avid traveler, James Katz, MD, is always looking for the next adventure. And pushing himself out of his comfort zone isn’t exclusive to his personal life. In his professional life, Dr. Katz broke free from the status quo with the Alcon AcrySof IQ PanOptix Trifocal IOL. Now, he wants his colleagues to know that this lens is an opportunity to give patients more out of life.
As surgeons, it’s our duty to offer our patients technology that will give them excellent visual outcomes.
“When I’m out skiing, there can be glare and reflections off the snow; there may be wind affecting my vision, or it can get foggy, which eliminates shadows and makes it hard to perceive depth. No matter what, improved function comes with good contrast and high-quality vision overall. I also try to achieve this with the PanOptix lens.”
James Katz, MD on Breaking Free:
Jim Katz, MD, is used to getting outside his comfort zone personally and professionally. He wants to instill that same confidence in his patients by using the AcrySof IQ PanOptix® Trifocal IOL by Alcon to meet the variety of visual demands they encounter—no matter what setting they are in.
Patients tend to value their vision more than other abilities, such as hearing or physical strength. When most patients can see well without glasses, it’s life-changing for them. I’ve seen their entire personalities change to become more positive and confident.
“To me, trying new things is a way to improve myself and feel more fulfilled, but it takes confidence to get there. I want my patients to have that confidence, too. I figure, if I can help them meet their visual demands, they’ll feel equipped to expand their horizons.”
Perhaps using advanced lens technology means stepping outside of your comfort zone. If that’s the case, I invite you to try something different. The reward will be an opportunity to give your patients more out of life.
“Breaking free was all about giving my patients the freedom to push outside their own comfort zones. When I consider their challenges, I first think about my own experiences. Some of the activities I love require different ranges of vision in a variety of lighting conditions.”
More surgeons on breaking free:
AcrySof® IQ PanOptix® Family of Trifocal IOLs
IMPORTANT PRODUCT INFORMATION
CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician.
INDICATIONS: The AcrySof® IQ PanOptix® Trifocal IOLs include AcrySof® IQ PanOptix® and AcrySof® IQ PanOptix® Toric and are indicated for primary implantation in the capsular bag in the posterior chamber of the eye for the visual correction of aphakia in adult patients, with less than 1 diopter of pre-existing corneal astigmatism, in whom a cataractous lens has been removed. The lens mitigates the effects of presbyopia by providing improved intermediate and near visual acuity, while maintaining comparable distance visual acuity with a reduced need for eyeglasses, compared to a monofocal IOL. In addition, the AcrySof® IQ PanOptix® Toric Trifocal IOL is indicated for the reduction of residual refractive astigmatism.
WARNINGS/PRECAUTIONS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Physicians should target emmetropia and ensure that IOL centration is achieved.
For the AcrySof® IQ PanOptix® Toric Trifocal IOL, the lens should not be implanted if the posterior capsule is ruptured, if the zonules are damaged or if a primary posterior capsulotomy is planned. Rotation can reduce astigmatic correction. If necessary, lens repositioning should occur as early as possible prior to lens encapsulation.
Some visual effects may be expected due to the superposition of focused and unfocused multiple images. These may include some perceptions of halos or starbursts, as well as other visual symptoms. As with other multifocal IOLs, there is a possibility that visual symptoms may be significant enough that the patient will request explant of the multifocal IOL. A reduction in contrast sensitivity as compared to a monofocal IOL may be experienced by some patients and may be more prevalent in low lighting conditions. Therefore, patients implanted with multifocal IOLs should exercise caution when driving at night or in poor visibility conditions.
Patients should be advised that unexpected outcomes could lead to continued spectacle dependence or the need for secondary surgical intervention (e.g., intraocular lens replacement or repositioning).
As with other multifocal IOLs, patients may need glasses when reading small print or looking at small objects. Posterior capsule opacification (PCO) may significantly affect the vision of patients with multifocal IOLs sooner in its progression than patients with monofocal IOLs. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure, available from Alcon, informing them of possible risks and benefits associated with the AcrySof® IQ PanOptix® Trifocal IOLs.
ATTENTION: Reference the Directions for Use labeling for each IOL for a complete listing of indications, warnings and precautions.
*Based on mean value of binocular defocus curve at near, intermediate and distance at 6 months (n=127).
†Snellen VA was converted from logMAR VA. A Snellen notation of 20/20-2 or better indicates a logMAR VA of 0.04 or better, which means 3 or more of the 5 ETDRS chart letters in the line were identified correctly.
1. AcrySof® IQ PanOptix® Directions for Use.
US-ACP-2000205
© 2020 Alcon Inc. 09/20
PanOptix is a trademark of Alcon. All other brand/product names are the trademarks of their respective owners.
